Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-074056

EVP, Chief Financial Officer acquired 75,000 shares (grant or award)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sawaf Aziz · EVP, Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-15 Grant or award : show line 1 in the form 10b5-1 +75,000 75,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-15 Grant or award : show line 2 in the form 10b5-1 Stock Option (Right to Buy) +150,000 150,000 D
Loading xslF345X06/wk-form4_1794849370.xml…